149 related articles for article (PubMed ID: 35643916)
1. Hematologic malignancies of primary bone marrow involvement: a decade's experience in Bahrain.
Ismaeel A; Farid E; Majed KS; Mansoor EJ; Toorani J; Tufail F; Aldanasoury RA; Alsuwaidi SA; Shome DK
Hematol Transfus Cell Ther; 2023 Jul; 45 Suppl 2(Suppl 2):S68-S75. PubMed ID: 35643916
[TBL] [Abstract][Full Text] [Related]
2. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
3. Leukemia incidence trends at the global, regional, and national level between 1990 and 2017.
Dong Y; Shi O; Zeng Q; Lu X; Wang W; Li Y; Wang Q
Exp Hematol Oncol; 2020; 9():14. PubMed ID: 32577323
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic polyclonality in hematologic malignancies.
Johansson B; Billström R; Broberg K; Fioretos T; Nilsson PG; Ahlgren T; Malm C; Samuelsson BO; Mitelman F
Genes Chromosomes Cancer; 1999 Mar; 24(3):222-9. PubMed ID: 10451702
[TBL] [Abstract][Full Text] [Related]
5. Nationwide statistical analysis of myeloid malignancies in Korea: incidence and survival rate from 1999 to 2012.
Park EH; Lee H; Won YJ; Ju HY; Oh CM; Ingabire C; Kong HJ; Park BK; Yoon JY; Eom HS; Lee E; Park HJ
Blood Res; 2015 Dec; 50(4):204-17. PubMed ID: 26770948
[TBL] [Abstract][Full Text] [Related]
6. Patterns of hematological and non-hematological malignancies in bone marrow in a tertiary care hospital in Nepal--11 years study.
Ghartimagar D; Ghosh A; Narasimhan R; Talwar OP
Nepal Med Coll J; 2012 Sep; 14(3):187-92. PubMed ID: 24047012
[TBL] [Abstract][Full Text] [Related]
7. Patterns of hematological malignancies in Chernobyl clean-up workers (1996-2005).
Gluzman D; Imamura N; Sklyarenko L; Nadgornaya V; Zavelevich M; Machilo V
Exp Oncol; 2006 Mar; 28(1):60-3. PubMed ID: 16614710
[TBL] [Abstract][Full Text] [Related]
8. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
9. Incidence and survival of hematological cancers among adults ages ≥75 years.
Krok-Schoen JL; Fisher JL; Stephens JA; Mims A; Ayyappan S; Woyach JA; Rosko AE
Cancer Med; 2018 Jul; 7(7):3425-3433. PubMed ID: 29654631
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Incidence of Hematologic Malignant Neoplasms Among Breast Cancer Survivors in France.
Jabagi MJ; Vey N; Goncalves A; Le Tri T; Zureik M; Dray-Spira R
JAMA Netw Open; 2019 Jan; 2(1):e187147. PubMed ID: 30657534
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
[TBL] [Abstract][Full Text] [Related]
12. A Rare Concurrence of Myelodysplastic Neoplasia and Tetrasomy 8 in a 3-Year-Old Bahraini Male.
Toorani ZA; Radhi AA; Hassan MM; Aloraibi AA
Cureus; 2023 Jul; 15(7):e41988. PubMed ID: 37593262
[TBL] [Abstract][Full Text] [Related]
13. Twenty-five years of epidemiological recording on myeloid malignancies: data from the specialized registry of hematologic malignancies of Cote d'Or (Burgundy, France).
Maynadié M; Girodon F; Manivet-Janoray I; Mounier M; Mugneret F; Bailly F; Favre B; Caillot D; Petrella T; Flesch M; Carli PM
Haematologica; 2011 Jan; 96(1):55-61. PubMed ID: 20971817
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
15. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes.
Aul C; Gattermann N; Schneider W
Br J Haematol; 1992 Oct; 82(2):358-67. PubMed ID: 1419819
[TBL] [Abstract][Full Text] [Related]
16. Copy number variations of EphA3 are associated with multiple types of hematologic malignancies.
Guan M; Liu L; Zhao X; Wu Q; Yu B; Shao Y; Yang H; Fu X; Wan J; Zhang W
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):50-3. PubMed ID: 21454190
[TBL] [Abstract][Full Text] [Related]
17. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies. A study on a large series of patients and cell lines.
Yokota S; Kiyoi H; Nakao M; Iwai T; Misawa S; Okuda T; Sonoda Y; Abe T; Kahsima K; Matsuo Y; Naoe T
Leukemia; 1997 Oct; 11(10):1605-9. PubMed ID: 9324277
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with hematological malignancies at gondar university hospital, North West Ethiopia.
Weldetsadik AT
Ethiop Med J; 2013 Jan; 51(1):25-31. PubMed ID: 23930488
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]